Product Description

🔹 Product Overview
GEFFON 250 mg Tablet is a prescription anticancer medicine used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients whose tumors have specific epidermal growth factor receptor (EGFR) mutations. It contains Gefitinib 250 mg, a targeted therapy that belongs to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) class. It works by slowing or stopping the growth of cancer cells.

🔹 Key Uses
Treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC)
Management of locally advanced or metastatic lung cancer
Helps slow the growth and spread of cancer cells
Targeted therapy for eligible patients as determined by EGFR testing

🔹 Composition
Active Ingredient: Gefitinib 250 mg
Drug Class: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)
Dosage Form: Oral Tablet

🔹 How It Works
Gefitinib blocks the activity of the epidermal growth factor receptor (EGFR), a protein that promotes the growth and division of certain cancer cells. By inhibiting EGFR signaling, GEFFON 250 mg helps slow or stop cancer cell growth and may reduce tumor progression in patients with EGFR mutation-positive NSCLC.

🔹 Key Benefits
Targeted treatment for EGFR-positive NSCLC
Helps slow cancer progression
May improve disease control in eligible patients
Once-daily oral tablet for convenient administration
Used under the supervision of an oncology specialist

🔹 Dosage and Administration
Take exactly as prescribed by your oncologist.
The usual recommended dose is 250 mg once daily.
Can be taken with or without food.
Swallow the tablet whole with water.
Continue treatment for as long as your doctor recommends.
If you miss a dose, follow your healthcare provider's instructions rather than taking an extra dose.

🔹 Possible Side Effects
Common side effects may include:
Diarrhea
Skin rash or acne-like rash
Dry skin
Nausea or vomiting
Loss of appetite
Mouth sores
Fatigue
Elevated liver enzymes
Seek immediate medical attention if you develop severe breathing problems, persistent cough, chest pain, or signs of serious liver injury.

🔹 Precautions
Use only under the supervision of a qualified oncologist.
Inform your doctor if you have liver disease, lung disease, or eye disorders.
Regular monitoring of liver function may be required.
Avoid pregnancy during treatment and use effective contraception as advised.
Inform your healthcare provider about all medicines and supplements you are taking to reduce the risk of drug interactions.
Do not breastfeed during treatment unless your doctor advises it is safe.